| Current Price | $6.29 | Mkt Cap | $706.4M |
|---|---|---|---|
| Open | $6.73 | P/E Ratio | 0.00 |
| Prev. Close | $6.76 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.28 - $6.79 | Volume | 1,930,594 |
| 52-Wk Range | $3.87 - $9.38 | Avg. Daily Vol. |
| Current Price | $6.29 | Mkt Cap | $706.4M |
|---|---|---|---|
| Open | $6.73 | P/E Ratio | 0.00 |
| Prev. Close | $6.76 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.28 - $6.79 | Volume | 1,930,594 |
| 52-Wk Range | $3.87 - $9.38 | Avg. Daily Vol. |
The best Bull and Bear pitches based on recency and number of recommendations.
TG Therapeutics has been a popular topic on biotwitter for a couple of years, but I never had the time to put the stock into my database so I wasn't around for the monster move from 5 to 18 last year. Would I have taken the plunge and started a real… More
Only a matter of time before this loses at least 1 Star. AT LEAST 1!
Read the most recent pitches from players about TGTX.
Recs
OklaBoston
(< 20)
Submitted: 7/23/2019 2:15:01 AM :
Start Price:
$7.80
NASDAQ:TGTX Score:
-17.13
Shrinking deficits primarily.
Recs
TurksFan
(42.96)
Submitted: 4/7/2018 8:43:26 AM :
Start Price:
$13.20
NASDAQ:TGTX Score:
-64.20
Starting my research into biotechs
Recs
TMFEBCapital
(89.66)
Submitted: 4/30/2017 1:16:33 PM :
Start Price:
$11.00
NASDAQ:TGTX Score:
-65.30
While it's anyone's guess if the FDA will require a second trial to confirm TG-1101s efficacy alongside Imbruvica in CLL before approving it, upcoming presentations in June at ASCO could help boost this company's shares over the coming month. After the conference, investors should have more info to digest on safety that could inform the chances of this drug getting across the regulatory finishline.
Find the members with the highest scoring picks in TGTX.
usubanas (99.65) Score: +131.16
The Score Leader is the player with the highest score across all their picks in TGTX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| BobbyCyclone | 28.67 | 3/5/2015 |
|
5Y | $16.05 | -60.81% | +38.77% | +99.58 | 0 Comment | |
| allforone | 30.21 | 12/31/2018 |
|
3Y | $4.10 | +53.41% | +17.77% | +35.64 | 0 Comment | |
| gearyservices | 31.76 | 3/29/2019 |
|
NS | $8.71 | -27.78% | +3.67% | +31.46 | 0 Comment | |
| sln | 72.69 | 7/1/2019 |
|
5Y | $8.85 | -28.93% | -1.46% | +27.46 | 0 Comment | |
| thiscoloradokid | < 20 | 11/14/2013 |
|
3M | $3.42 | +83.92% | +63.17% | +20.75 | 0 Comment | |
| TMFHorst | 97.72 | 7/22/2019 |
|
5Y | $7.97 | -21.08% | -2.53% | +18.55 | 0 Comment | |
|
Baseballmom1123 | < 20 | 11/20/2013 |
|
3Y | $3.49 | +80.23% | +63.82% | +16.41 | 0 Comment |
| drugtrader | 90.06 | 10/8/2018 |
|
5Y | $5.35 | +17.57% | +1.84% | +15.73 | 0 Comment | |
| DrDoofenshmirtz | 99.87 | 9/27/2018 |
|
5Y | $5.53 | +13.85% | +0.32% | +13.53 | 0 Comment | |
| efarev | 98.44 | 10/1/2018 |
|
5Y | $5.60 | +12.32% | +0.08% | +12.24 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackJimCramer | 86.47 | 1/6/2015 |
|
3W | $15.70 | -59.94% | +46.30% | -106.24 | 0 Comment |
